Categories: Post

Biomedical Research

At no other time in history have we been this close to translating basic scientific discoveries into novel therapeutic strategies to benefit humankind. However, the traditional missions of academic institutions and the pharmaceutical industry are almost diametrically opposed. Have we reached the point where ‘publish or perish’ is being replaced by ‘patent and prosper’? Participants had a timely discussion with Dr. Mary Hendrix, President and Scientific Director, Children’s Memorial Research, about the role of industry competitiveness in biomedical research and its impact on the future of health care.

c2st

Recent Posts

Rare Disease Research with Big Impact: What is Rett Syndrome?

While few have heard of this rare disease, the research behind Rett Syndrome is pushing…

5 days ago

AI in Medicine: Breakthrough Model Transforms Diagnosis

Imagine walking into a medical office and receiving a diagnosis in minutes rather than days.…

5 days ago

An Interview with Dr. Masahito Jimbo, an expert in patient – physician communication

Here's the What, Why, and Where from my interview with Dr. Mashito Jimbo. Dr. Jimbo…

6 days ago

Excavating the Field of Zooarchaeology: An Interview With Archaeologist Dr. Kate Bishop

Humans and animals have had complex relationships with one another throughout history. From domestication to…

1 week ago

Rare Disease, Real Results: The Team That’s Exploding Research for a Rare Brain Disorder

Imagine your child is sick, and no amount of doctor visits provides a satisfying answer…

1 week ago